FDA delays Gattex decision

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said FDA extended the PDUFA date by three months for an NDA for Gattex teduglutide to treat short bowel syndrome (SBS). The new date is Dec. 30; it was Sept. 30....